Multiple Sclerosis Research Review, Issue 15

In this issue:

MMP9 is decreased in natalizumab-treated MS patients at risk for PML
Cervical cord volume loss in CIS and early MS
Fampridine response in MS patients with gait impairment
A pro-tolerogenic shift in blood leukocyte profile associates with an optimal response to DMF in MS
Comparative effectiveness of rituximab vs GA or IFN-β in RRMS
Safety of IVMP during breastfeeding in MS patients
NFL levels in patients with MS switching from injectable therapies to fingolimod
Smoking and MS: A systematic review and meta-analysis
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in SPMS
Baseline predictors of persistence to first disease-modifying treatment in MS

Please login below to download this issue (PDF)

Subscribe